Metronomic Chemotherapy for Metastatic Breast Cancer – a Systematic Review of the Literature - sprookjes - yvandenbroek - TriplyDB

Metronomic Chemotherapy for Metastatic Breast Cancer – a Systematic Review of the Literature

Metronomic Chemotherapy for Metastatic Breast Cancer – a Systematic Review of the Literature

http://www.wikidata.org/entity/Q26745462

about

Molecular expression of vascular endothelial growth factor, prokineticin receptor-1 and other biomarkers in infiltrating canalicular carcinoma of the breast Metronomic Chemotherapy: Seems Prowess to Battle against Cancer in Current Scenario Metronomic Chemotherapy for Primary Non-Metastatic Breast Cancer - a Systematic Review of the Literature.Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies.Metronomic chemotherapy remodel cancer-associated fibroblasts to decrease chemoresistance of gastric cancer in nude mice.Explorative Analysis of Low-Dose Metronomic Chemotherapy with Cyclophosphamide and Methotrexate in a Cohort of Metastatic Breast Cancer Patients

P2860

Q37289550-2410FE9B-14FA-4905-A530-43045B9B6132 Q37543011-73083961-9FF5-48AA-B600-EE3DB4C1C261 Q37709874-0865B707-EA23-436B-8464-F9A3244714BD Q47554623-9FAF76A0-DDD9-453A-98D4-463DC512EA61 Q49520667-0BCEF717-E818-4B19-830E-964ADFC62BB5 Q57495758-81110A8E-420C-46EF-A565-B871E6B94F00

P2860

Metronomic Chemotherapy for Metastatic Breast Cancer – a Systematic Review of the Literature

http://www.wikidata.org/entity/Q26745462

description

2016 nî lūn-bûn

@nan

2016 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Metronomic Chemotherapy for Me ...... matic Review of the Literature

@ast

Metronomic Chemotherapy for Me ...... matic Review of the Literature

@en

Metronomic Chemotherapy for Me ...... matic Review of the Literature

@nl

type

label

Metronomic Chemotherapy for Me ...... matic Review of the Literature

@ast

Metronomic Chemotherapy for Me ...... matic Review of the Literature

@en

Metronomic Chemotherapy for Me ...... matic Review of the Literature

@nl

prefLabel

Metronomic Chemotherapy for Me ...... matic Review of the Literature

@ast

Metronomic Chemotherapy for Me ...... matic Review of the Literature

@en

Metronomic Chemotherapy for Me ...... matic Review of the Literature

@nl

P1433

Q26745462-48C40246-85B3-4DD6-8A9A-7A07C1ECF73F

P1476

Q26745462-BAFC51CF-5539-45C3-9F4E-9E68CA0977EF

P2093

Q26745462-06D54ACE-FD70-4CC4-8A35-034CADDBB363

Q26745462-1E19D159-A52F-4057-8CA6-D0EDEBA6FAA6

Q26745462-1FE2284E-9AC5-480E-8A20-EDE891D3B718

Q26745462-A2ACCB8C-575C-40BB-9FDC-7D4974B85872

Q26745462-DB717629-C930-4502-9A5B-1614D6C681C0

P2860

Q26745462-064DE1F1-3C79-428F-A5BD-4C16D44BE99C

Q26745462-095F2DDB-C77B-4FF9-BC1D-886479B8216F

Q26745462-0995EE73-D817-4C20-B092-1D325EEDA578

Q26745462-0BC46C03-2C31-41A4-9A7A-DF827B6780A8

Q26745462-0F29C5E1-EF7F-4FB1-9265-4E20D7F23B48

Q26745462-132940D0-30FF-4F68-AE2D-9D2742B24827

Q26745462-16931607-1843-4CB1-A0DA-72C324BDA4F1

Q26745462-1719DE27-E953-4C88-AF9B-85FB2F011A8F

Q26745462-1A73729E-D0FA-479F-97F3-81FB9DD6ED6D

Q26745462-1D1EC665-3E53-46DE-A29A-CF37BE2C4B38

P304

Q26745462-C23777E0-D887-43EC-8814-85B076B8F811

P31

Q26745462-48D1C00F-D2B3-43D8-9A53-D80B1BD6ED9B

Q26745462-4B4B7C59-C711-4120-B9E0-7BFA04EAC52B

P356

Q26745462-15352097-1A92-42DF-8E1E-42886B762295

P433

Q26745462-E6D8A4D8-F916-4895-B0F5-0650F4EE7F3F

P478

Q26745462-CB1FE31B-FB7B-4DFF-9DEE-6FA10723202B

P577

Q26745462-608DA594-C59B-408D-B8CC-1C35C24635B0

P698

Q26745462-EA65D0B4-59B7-476E-9519-294BD8C1EEB9

P921

Q26745462-847F008B-CCE0-46F8-8EE8-ABBA49E2E18A

Q26745462-C6868DF3-8B02-496E-9C69-252B5AA70A9B

P932

Q26745462-F2BD6B45-8CBE-4604-A70F-34761777321D

P356

P1433

Geburtshilfe und Frauenheilkunde: Ergebnisse der Forschung für die Praxis

P1476

Metronomic Chemotherapy for Me ...... matic Review of the Literature

@en

P2093

E Ruckhäberle

http://www.w3.org/2001/XMLSchema#string

F Schütz

http://www.w3.org/2001/XMLSchema#string

M Banys-Paluchowski

http://www.w3.org/2001/XMLSchema#string

N Krawczyk

http://www.w3.org/2001/XMLSchema#string

T Fehm

http://www.w3.org/2001/XMLSchema#string

P2860

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

Thalidomide is an inhibitor of angiogenesis

Immune targeting in breast cancer

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer

Low-dose oral fluorouracil with eniluracil as first-line chemotherapy against advanced breast cancer: a phase II study

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer

Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism

Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer

Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients.

P304

525-534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P356

10.1055/S-0042-105871

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27239061

http://www.w3.org/2001/XMLSchema#string

P921

obstetrics and gynaecology

P932

4873299

http://www.w3.org/2001/XMLSchema#string